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Background: A number of compounds, including ascorbic acid, catecholamines, flavonoids, 
p-diphenols and hydrazine derivatives have been reported to interfere with peroxidase-based 
medical diagnostic tests (Trinder reaction) but the mechanisms of these effects have not been 
fully elucidated. 
Methods: Reactions of bovine myeloperoxidase with o-dianisidine, bovine lactoperoxidase 
with ABTS and horse radish peroxidase with 4-aminoantipyrine/phenol in the presence of 
carbidopa, an anti-Parkinsonian drug, and other catechols, including L-dopa, were monitored 
spectrophotometrically and by measuring hydrogen peroxide consumption. 
Results: Chromophore formation in all three enzyme/substrate systems was blocked in the 
presence of carbidopa and other catechols. However, the rates of hydrogen peroxide 
consumption were not much affected. Irreversible enzyme inhibition was also insignificant.  
Conclusions: Tested compounds reduced the oxidation products or intermediates of model 
substrates thus preventing chromophore formation. This interference may affect interpretation 
of results of diagnostic tests in samples from patients with Parkinson’s disease treated with 
carbidopa and L-dopa. 
General significance: This mechanism allows prediction of interference in peroxidase-based 




Peroxidases are heme-containing oxidoreductases catalyzing the oxidation of a variety 
of substrates with hydrogen peroxide. Mammalian peroxidases include enzymes involved 
primarily in defense reactions (myeloperoxidase, MPO; eosinophil peroxidase, EPO; 
lactoperoxidase, LPO) and thyroid hormone biosynthesis (thyroid peroxidase, TPO) [1]. The 
antimicrobial activity of MPO, EPO, and LPO results from their ability to convert halides, 
thiocyanate, and nitrite to compounds (e.g. hypohalous acids) that are highly toxic to invading 
microorganisms [2, 3]. These enzymes also participate in the metabolism of xenobiotics, 
including drugs [4], and some of them, particularly MPO, have been implicated in the 
pathogenesis of many diseases, such as atherosclerosis, Alzheimer’s disease, Parkinson’s 
disease, and cancer [5, 6]. Therefore substantial efforts have been made to develop inhibitors 
of MPO with perspectives for clinical applications [7, 8].  
Hydrazine derivatives have been widely used in medicine and include the primary 
anti-tuberculosis drug isoniazid, the anti-cancer agent procarbazine, the anti-Parkinsonians 
carbidopa and benserazide, and the older generation anti-depressants iproniazid and 
phenelzine [9]. Peroxidases oxidize hydrazine derivatives generating radical products that 
generally inactivate these enzymes by covalent binding to the heme prosthetic group or the 
polypeptide chain [10]. The effect of phenylhydrazine has been particularly well studied on 
horseradish peroxidase (HRP) [11], LPO [12] and lacrimal-gland peroxidase [13]. Substantial 
efforts have also been made to elucidate the interactions of peroxidases with isoniazid [14-17] 
in attempts to understand the action of this drug on the Mycobacterium tuberculosis catalase-
peroxidase (MtCP, KatG) [18]. Inhibition of peroxidases by isoniazid also led to 
investigations of these enzymes with a number of benzoic acid hydrazides [19-22].  
We have recently synthesized a potential tyrosinase-activated anti-melanoma prodrug 
with a hydrazine linker [23]. Before designing such prodrugs we tested the reaction of 
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carbidopa ((2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid, 1, Fig. 1) to 
determine the reaction pathway following the oxidation of a compound containing both a 
hydrazine group and a catechol moiety by tyrosinase [24]. However, since prodrugs with such 
a structure, before reaching the target tissues, would be exposed to the oxidative systems in 
the blood, we also decided to test their oxidation by mammalian peroxidases. It has been 
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Figure 1. Structures of compounds used in this study: 1 – (S)-carbidopa ((2S)-3-(3,4-
dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid; 2 – L-dopa ((S)-2-amino-3-(3,4-
dihydroxyphenyl)propanoic acid), 3 – dopamine (2-(3,4-dihydroxyphenyl)ethylamine);  
4 – HX1 (2-(3,5-bistrifluoromethylbenzylamino)-6-oxo-1H-pyrimidine-5-carbohydroxamic 
acid; 5 – 3-(3,4-dihydroxyphenyl)propanoic acid; 6 – 3,4-dihydroxyphenylacetic acid;  
7 – hydrazine; 8 – phenelzine (2-phenylethylhydrazine); 9 – isoniazid (isonicotinic acid 
hydrazide); 10 – benzhydrazide.  
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with mammalian peroxidases have not been studied so far. Here we show that HRP, bovine 
MPO and LPO oxidize carbidopa to the same products as tyrosinase. We also show that this 
drug and other catechol-containing compounds (2, 3, 5, and 6, Fig. 1) interfere with the 
oxidation of standard peroxidase substrates, such as o-dianisidine, ABTS, and 4-amino-
antipyrine/phenol. This effect results primarily from reduction of the products or 
intermediates of the oxidation of these substrates not from reversible or irreversible inhibition 
of these enzymes.  
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2. Materials and Methods 
 
2.1. Reagents 
Carbidopa was obtained from Sochinaz SA (Vionnaz, Switzerland). HRP, bovine LPO, 
o-dianisidine, 4-aminoantipyrine, 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) 
diammonium salt (ABTS), L-3,4-dihydroxyphenylalanine (L-dopa), dopamine, 3-(3,4-
dihydroxyphenyl)propanoic acid, 3,4-dihydroxyphenylacetic acid, phenelzine, isoniazid, and 
HPLC grade acetonitrile were purchased from Sigma-Aldrich. Hydrogen peroxide, phenol, 
hydrazine hydrate, xylenol orange, buffer components and solvents were from Avantor 
Performance Materials (Gliwice, Poland), SDS was from Fluka, and benzhydrazide from Alfa 
Aesar. MPO was purified from bovine spleen according to published procedures [26, 27]. 
Tyrosinase was isolated from mushrooms as described previously [28].  
2.2. Spectrophotometric analysis of the oxidation of carbidopa by peroxidases and 
tyrosinase 
Solutions of carbidopa were prepared fresh daily in 1 mM phosphoric acid to prevent 
autooxidation. Reactions with peroxidases were carried out at room temperature in 3 ml of 
50 mM Sörensen buffer, pH 6.0, with 10-500 M carbidopa in the presence of equimolar 
concentration of H2O2 and 20 to 500 nM enzymes. The concentration of the enzymes was 
calculated from the absorbance of their Soret bands using their extinction coefficients: 
91000 M-1×cm-1 at 430 nm for bovine MPO [21], 112000 M-1×cm-1 at 412 nm for bovine 
LPO [29], and 102000 M-1×cm-1 at 403 nm for HRP [30]. Reactions were initiated by the 
addition of either hydrogen peroxide or the enzymes. Reactions with tyrosinase were carried 
out in 50 mM sodium phosphate buffer, pH 6.8. The concentration of tyrosinase was 
determined using the Bradford assay with bovine serum albumin as a standard. UV/Vis 
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spectra from 250 to 700 nm were recorded in a Jasco V-650 UV-Vis spectrophotometer 
immediately after mixing the reagents and then in 1 or 2 min intervals.  
2.3. HPLC Analysis 
The reactions with peroxidases were carried out in 0.5 ml of 50 mM Sörensen buffer, 
pH 6.0, with 500 M carbidopa in the presence of 500 M H2O2 and 50 to 500 nM enzymes. 
Samples were incubated at room temperature for 0-120 min and then the enzymes were 
removed from the reaction mixtures by ultrafiltration on Microcons Ultracel YM-10 (Merck 
Millipore). The filtrates were then separated at 30 °C on an Accucore C18 analytical column 
(100 mm length, 2.1 mm diameter, 2.6 μm particle size, Thermo Scientific) with a guard 
column connected to a Dionex UltiMate 3000 HPLC instrument equipped with a UV-Vis 
photodiode array detector at a flow rate of 0.2 ml/min. Samples were injected into a 5 l loop 
and then eluted with the following program: 5% acetonitrile in water for 3 min, 5-50% 
gradient of acetonitrile in water for 14 min, followed by 90% acetonitrile in water for 1 min. 
The identity of all products was confirmed by LC-MS analysis on a Dionex UltiMate 3000 
HPLC connected to a Bruker Daltonik micrOTOF-Q II mass spectrometer with ESI ionization 
in the positive or negative ion mode. The mass spectrometer was calibrated with sodium 
formate clusters. 6,7-Dihydroxy-3-methylcinnoline and 3-(3,4-dihydroxyphenyl)-2-
methylpropanoic acid were prepared by oxidation of carbidopa with tyrosinase in a large scale 
reaction (50 mg), purified as described previously [24] and used as standards.  
2.4. Oxidation of model substrates in the presence of carbidopa and other catechols 
The peroxidatic activity of bovine MPO was measured with o-dianisidine. The 
reaction mixture consisted of 50 mM Sörensen buffer, pH 6.0, 100 M o-dianisidine, 50 M 
H2O2, 2-20 nM enzyme, and various concentrations of carbidopa, L-dopa, 3-(3,4-
dihydroxyphenyl)propanoic acid or 3,4-dihydroxyphenylacetic acid (1-40 M). Changes in 
absorbance at 460 nm resulting from the oxidation of o-dianisidine were measured for 30 min.  
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The peroxidatic activity of bovine LPO was measured with either o-dianisidine under 
conditions identical to reactions with bovine MPO or 2,2-azino-bis(3-ethylbenzothiazoline-6 
sulfonic acid) diammonium salt. The reactions with 25 M ABTS were carried out in 50 mM 
Sörensen buffer, pH 6.0, with 25 μM H2O2, and 1-10 nM LPO. Absorbance of the oxidized 
ABTS product (ABTS+•) at 415 nm was monitored for 30 min. The same catechols as for 
MPO were applied at the same concentrations.  
The activity of horseradish peroxidase was tested in 50 mM phosphate buffer, pH 7.0 
with 50 μM 4-aminoantipyrine, 1 mM phenol, 50 μM H2O2, 0.5 or 1.0 μg of HRP, and various 
concentrations of carbidopa, L-dopa, dopamine, 3-(3,4-dihydroxyphenyl)propanoic acid or 
3,4-dihydroxyphenylacetic acid. The tested compounds were applied at 10-160 μ. Spectra 
from 250 to 700 nm were recorded in a Jasco V-650 UV-Vis spectrophotometer immediately 
after mixing the reagents and then in 1 min intervals for 30 min. Additionally the same 
reactions were performed and the absorbance at 505 nm was measured for 10-30 min. 
Hydrogen peroxide consumption was measured under the same conditions as the 
reactions monitored spectrophotometrically with the modified xylenol orange method 
including sorbitol [31]. Aliquots of the reaction mixtures were removed at 1 min intervals, 
mixed with the xylenol orange reagent, incubated in the dark for 30 min and the absorbance 
was measured at 560 nm. Under the reaction conditions (25 mM sulfuric acid) the catechols 
used in this study did not interfere with this assay (Fig. S1). 
2.5. Analysis of meriquinone reduction 
Reduction of meriquinone, the intermediate in the oxidation of o-dianisidine by 
peroxidases, was performed according to published procedures [32, 33] with slight 
modifications. Reactions were carried out at room temperature in 50 mM sodium acetate 
buffer, pH 4.0, with 100 μM o-dianisidine, 100 μM H2O2, 20 nM MPO in the presence of 
200 μM SDS (1 mM SDS used previously in this assay with HRP [32, 33] strongly inhibited 
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bovine MPO) for 10 min. After that time, when the absorbance of meriquinone at 395 nM 
stabilized, the tested compounds at concentration 10 μM, 25 μM or 50 μM were added. The 
following compounds were analyzed: carbidopa, L-dopa, 3-(3,4-dihydroxyphenyl)propanoic 
acid, 3,4-dihydroxyphenylacetic acid, hydrazine, phenelzine, benzhydrazide, and isoniazid. 
Changes in absorbance at 395 nm were then measured for 10-30 min. 
2.6. Analysis of irreversible enzyme inhibition 
Bovine MPO or LPO at 1.5 μM concentration were incubated with various 
concentrations of carbidopa (15-1500 M) in the presence of equimolar concentration of H2O2 
in 50 mM Sörensen buffer, pH 6.0 in a final volume of 0.5 mL for 1 h at room temperature 
and then the reaction components were separated by dialysis overnight (20-22 h) at 4°C. 
Originally the enzymes were separated from the low molecular mass components by gel 
filtration on Sephadex G-25 columns. However, large part of the enzyme was retained on the 
column, which indicated substantial protein cross-linking, as would be expected during 
oxidation of a compound containing both a catechol and a hydrazine group. This method was 
therefore abandoned. After dialysis the protein concentration was determined 
spectrophotometrically with the Bradford method and the UV-Vis spectra of the enzymes in 
the 250-700 nm range were also recorded. The peroxidatic activity was then measured with o-
dianisidine as described above.  
2.7. Molecular modeling 
Molecular docking experiments of carbidopa to human MPO (PDB ID: 1D2V) [34] 
and bovine LPO (PDB ID: 3Q9K) were carried out using AutoDock Vina 1.1.2 [35] and 
AutoDockTools 1.5.6 [36] with standard protocols. The crystal structures with the highest 
resolutions among those deposited in the Protein Data Bank were chosen as the template 
structures. A 28 × 30 × 28 Å grid box with the level of exhaustiveness set at 20 was used to 
cover all the space of ligand-binding pocket around the heme. The ionized form of the ligand 
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generated by the wash command of Molecular Operating Environment (MOE) software 
(MOE version 2014.09; Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite 
#910, Montreal, QC, Canada, H3A 2R7, 2014) was used for the docking experiments. The 
rotatable bonds of the small molecules were applied as default settings. The graphical 




3.1. Oxidation of carbidopa by peroxidases and tyrosinase 
Spectrophotometric analysis of mixtures of bovine MPO or LPO with carbidopa 
showed slow changes of absorbance in the visible and near-UV region with a maximum of 
absorption at ca. 365 nm (Fig. S2A and B), seen previously during reactions of this compound 
with HRP [25] (Fig. S2C). These spectra were very similar to the spectrum of the product 
obtained after oxidation of carbidopa by tyrosinase (Fig. S2D), which we have previously 
identified as 6,7-dihydroxy-3-methylcinnoline [24]. The reaction rates were, however, much 
smaller than in the case of tyrosinase (35-fold for bovine MPO and 16-fold for bovine LPO) 
and also smaller than for HRP (11-fold for bovine MPO and 5.2-fold for bovine LPO, based 
solely on the absorption at 365 nm). We also analyzed the reaction mixtures by HPLC to 
determine their composition. The reaction mixture with tyrosinase contained products 
identified previously [24], i.e. 6,7-dihydroxy-3-methylcinnoline, 3-(3,4-dihydroxyphenyl)-2-
methylpropanoic acid, and 3,4-dihydroxyphenylacetone (Fig. S3D). These compounds were 
also present in reaction mixtures with peroxidases, although in much smaller quantities (Fig. 
S3A-C), as was expected from the spectrophotometric analysis.  
3.2. Spectrophotometric analysis of the influence of carbidopa on the peroxidatic activity 
of bovine MPO and LPO 
Since carbidopa was oxidized very slowly by the bovine enzymes, we decided to 
investigate its potential to inhibit them using model substrates (o-dianisidine and ABTS). In 
the spectrophotometric analysis the presence of carbidopa resulted in a dramatic decrease of 
absorbance in reactions with both enzymes (Fig. 2). Essentially no absorption in the range of 
the oxidation products of o-dianisidine in the case of bovine MPO and o-dianisidine or ABTS 
in the case of bovine LPO was detected in the initial phase of the reactions. However, at lower 
carbidopa concentrations the activity was recovered to a substantial degree after a lag period, 
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as would be expected for a compound which also served as a substrate for both enzymes. At 
higher concentrations the lag period was no longer proportional to concentration and was even 
extended indefinitely (until the end of the measurement time - up to 120 min). These results 
indicated that carbidopa may act as a suicide substrate, just as other hydrazine derivatives, and 
the activity may be retained only after a limited turn-over number. This effect may have also 
been caused by disruption of the peroxidase cycle. While carbidopa may have been readily 
oxidized by compound I, it may have been a poor substrate for compound II leading to 
accumulation of the latter, as it has been demonstrated for a number of compounds, such as 

































































Figure 2. Influence of carbidopa on the peroxidatic activity of bovine MPO (A) and LPO (B) 
measured spectrophotometrically. The oxidation of 100 M o-dianisidine with 50 M H2O2 
and 5 nM MPO was monitored at 460 nm (A) and the oxidation of 25 M ABTS with 25 M 
H2O2 and 2 nM LPO was monitored at 415 nm (B) in the absence (0) or presence of carbidopa 
at concentrations shown next to each curve. The concentrations of the enzymes and carbidopa 
were chosen to best show the changes in the lag period.  
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3.3. Irreversible inhibition of bovine peroxidases by carbidopa 
Prolonged incubation of bovine MPO and PLO with carbidopa and H2O2 led to partial 
loss of activity, but the concentration of carbidopa necessary to achieve this effect was quite 
high. Even at the substrate to enzyme ratio equal 1000:1 (1.5 mM:1.5 M) both enzymes still 
retained substantial activity (Fig. 3). The inhibitory effect was slightly stronger for bovine 
MPO than for bovine LPO, confirming the results of the oxidation of carbidopa by both 
enzymes (spectrophotometric and chromatographic analysis). Partition ratios [37] calculated 
from these results were 1240 and 1460 for bovine MPO and bovine LPO, respectively. These 
numbers are quite high when compared to other irreversible peroxidase inhibitors, including 
hydrazine derivatives. For phenelzine and HRP the partition ratio was 11 [38], and for the 
very effective irreversible thioxanthine inhibitor TX2 and human MPO – only 0.2 [39]. The 
UV-Vis spectra of the enzymes recorded after incubation with carbidopa and dialysis have 
shown little changes in the heme Soret bands (data not shown), which indicated that the 


























Figure 3. Irreversible inactivation of 1.5 M bovine MPO ( ) and bovine LPO ( ) 
determined after incubation with carbidopa for 1 h followed by dialysis. Enzyme activity was 
monitored with o-dianisidine as a substrate. The activity was calculated with respect to a 
control reaction with the enzyme which was treated in the same way in the absence of 
carbidopa and H2O2.  
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3.4. Molecular docking of carbidopa to human MPO and bovine LPO 
The relatively inefficient irreversible inhibition of MPO and LPO by carbidopa can be 
attributed to the presence of the o-diphenol moiety, which may preferentially interact with the 
active site preventing the oxidation of the hydrazine group followed by covalent modification 
of the enzymes’ active sites. The hydrophobic character of the access channel may lead to 
preferential orientation of carbidopa with the catechol group directed towards the heme center. 
Formation of 6,7-dihydroxy-3-methylcinnoline by both enzymes, which proceeds via the o-
quinone intermediate, also seemed to support this hypothesis. This mode of oxidation of 
carbidopa could explain, at least in part, the lack of its reported carcinogenic effects. We 
performed molecular docking experiments of carbidopa to human MPO (PDB ID: 1D2V) [34] 
and bovine LPO (PDB ID: 3Q9K) using AutoDock Vina 1.1.2 [35]. Since no crystal 
structures are available for bovine MPO we have used human MPO which has 87% identity 
with bovine MPO. In the best-scored structures the orientation of carbidopa was indeed as we 
expected – with the catechol group directed towards the heme forming a network of hydrogen 
bonds (Fig. S4 and S5). While a single structure with a binding energy of -7.1 kcal×mol-1 was 
obtained for human MPO, the experiments with bovine LPO provided two top-scored 
structures with equal binding energies of -6.8 kcal×mol-1. The observation of the two equally 
favored ligand orientations in bovine LPO suggests that the reversible interaction of carbidopa 
with the heme distal side of this enzyme is weaker than with the human MPO. The detailed 
results of these experiments are presented in the Supplementary Material.  
3.5. Changes in H2O2 concentration during oxidation of model substrates by bovine 
MPO and LPO in the presence of carbidopa 
Since we excluded irreversible inhibition of MPO and LPO by carbidopa, we looked 
for other mechanisms that could explain the lack of chromophore formation during reactions 
 15 
with o-dianisidine and ABTS (Fig. 2). It may have resulted from preferential oxidation of 
carbidopa by peroxidases until its depletion or reduction of the oxidation products of standard 
substrates. This effect was particularly likely for ABTS+•, which is frequently used to 
determine antioxidant activity [40] and is readily reduced by a number of compounds, 
including polyphenols [41, 42].  
To determine which of these two mechanisms is involved we monitored hydrogen 
peroxide consumption during the oxidation of o-dianisidine by MPO and ABTS by LPO in 
the presence of carbidopa. Changes in H2O2 concentration did not correspond to changes in 
absorbance. In the reactions with MPO and o-dianisidine moderate decrease in the reaction 
rates was observed in the presence of carbidopa and the effect was proportional to its 
concentration but no lag periods were observed (Fig. 4A). These results demonstrated that in 
this case both competitive oxidation of carbidopa (at a rate lower than for o-dianisidine) and 




























































Figure 4. Changes in H2O2 concentration during oxidation of o-dianisidine by bovine MPO 
(A) and ABTS by bovine LPO (B) measured by the modified xylenol orange assay. Reactions 
were carried out under conditions identical as in Figure 1 in the absence (●) or presence of 
2 M (□), 4 M (), 6 M (■), 8 M (○), and 10 M (▲) carbidopa.  
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during the lag period) took place. In reactions with LPO and ABTS a slight increase in the 
reaction rate was observed in the presence of carbidopa, although no correlation with its 
concentration could be seen (Fig. 4B). This effect can be attributed to reduction of ABTS+• 
back to ABTS, whose concentration is maintained close to the initial value until carbidopa is 
consumed. Also, the final values of H2O2 concentration were lower in the presence of 
carbidopa than in its absence.  
3.6. Reduction of meriquinone by carbidopa and other catechols 
When we oxidized ABTS with bovine LPO and added carbidopa to the reaction 
mixture it was decolorized immediately. This effect could not be reproduced with o-
dianisidine, which demonstrated that it was not the final oxidation product, which was 
reduced by carbidopa but one of the reaction intermediates. Such an intermediate, a charge 
transfer complex between the substrate and the quinonediimine product named meriquinone 
[43], may be stabilized by SDS at low pH [32]. We have therefore generated meriquinone in 
reactions of o-dianisidine with MPO and tested the effect of carbidopa on its concentration. 
Results of this experiment clearly demonstrated that carbidopa could reduce this intermediate 
(Fig. 5). To determine the role of each of the reducing groups in carbidopa (catechol and 
hydrazine) we performed this analysis with several catechols (L-dopa, 3-(3,4-
dihydroxyphenyl)propanoic acid, 3,4-dihydroxyphenylacetic acid) and with hydrazine and 
several of its derivatives (phenelzine, benzhydrazide, isoniazid). The effect of all catechol-
containing compounds was similar to that of carbidopa, while the influence of hydrazine and 
its derivatives was small or negligible (Fig. S6). We also analyzed the oxidation of  
o-dianisidine by peroxidases in the presence of these catechols under standard assay 
conditions. In all cases lack of absorbance at 460 nm in the initial phase of the reactions 































Figure 5. Reduction of meriquinone by carbidopa. After oxidation of 100 μM o-dianisidine 
with 100 μM H2O2 and 20 nM MPO in the presence of 200 μM SDS in 50 mM acetate buffer, 
pH 4.0 for 10 min (time 0) the reaction was monitored at 395 nm in the absence of carbidopa 
(0) or in its presence at concentrations shown next to each curve. 
 
3.7. Influence of carbidopa and other catechols on the oxidation of 4-aminoantipyrine by 
HRP 
It therefore became obvious that carbidopa and the other tested catechols interfered 
with bovine MPO and LPO-catalyzed reactions with both o-dianisidine and ABTS as 
substrates by reducing their oxidation products or intermediates leading to changes in 
absorbance which did not reflect changes in reaction rates. We have therefore decided to 
study their effects on reactions catalyzed by horseradish peroxidase with 4-aminoantipyrine as 
a substrate. This reaction is applied in many medical diagnostic tests and a number of 
compounds have been reported to interfere with it. Such an effect was first discovered for 
tolazamide with three substrate systems: 4-aminoantipyrine, guaiacum, and ABTS [44], and 
later for another hydrazine derivative – gliclazide [45]. It was also reported for N-
acetylcysteine [46], acetaminophen with MBTH used as a substrate [47], and is particularly 
well documented for ascorbic acid [48-50]. Most importantly, however, such interference was 
also described for catechol-containing compounds – first for dopamine, which interfered with 
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creatinine measurements [51], and later for dopamine and dobutamine, which affected 
detection of several analytes (cholesterol, triglycerides, and uric acid) [52, 53]. More recently 
such an effect was also reported for norepinephrine and epinephrine, although for these two 
compounds physiological and therapeutic concentrations are too low to cause significant 
interference in diagnostic tests [54].  
When we carried out oxidation of 4-aminoantipyrine/phenol by HRP in the presence 
of carbidopa and monitored the reactions spectrophotometrically, we obtained results very 
similar to those observed for o-dianisidine/MPO and ABTS/LPO – a lag period in the increase 
of absorbance of the quinoneimine chromophore and a decrease in the final absorbance 
proportional to carbidopa concentration (Fig. 6). However, measurements of changes in 
hydrogen peroxide concentration again have shown that the reaction rates were essentially 
unaffected by the presence of carbidopa (Fig. 7). These results demonstrate that in this system 
(HRP/4-aminoantipyrine/phenol) carbidopa is not an effective competing substrate as it was 






























Figure 6. Changes of absorbance at 505 nm during oxidation of 50 M 4-aminoantipyrine 
and 1 mM phenol with 100 M H2O2 by 0.5 g of HRP in the absence (0) or presence of 
carbidopa at concentrations shown next to each curve. The concentrations of the enzyme and 
































Figure 7. Changes in H2O2 concentration during oxidation of 50 M 4-aminoantipyrine and 
1 mM phenol with 100 M H2O2 by 0.5 g of HRP in the absence (●) or presence of 10 M 
(□), 20 M (○), 40 M (■), and 80 M (▲) carbidopa.  
 
formation and the final concentration of antipyrilquinoneimine are due primarily to the 
reduction of the reaction intermediates (most likely the antipyril radical) by this compound.  
Similar results were also obtained for other catechols tested before with MPO and o-
dianisidine and LPO with o-dianisidine and ABTS as substrates (L-dopa, 3-(3,4-
dihydroxyphenyl)propanoic acid, 3,4-dihydroxyphenylacetic acid). For comparison we also 
performed this analysis for dopamine, whose effects on HRP-catalyzed reactions with 4-
aminoantipyrine/phenol were previously reported [51-53, 55, 54]. Although the lag phases 
were not as clear as in the case of carbidopa, the rates of increase of absorbance at 505 nm 
and their final values were lower in the presence of all catechols than in their absence (Fig. 
S8). The differences between the shapes of these curves can be explained by the absorption 
spectra of the oxidation products of carbidopa an the other catechols. While the oxidation 
products of carbidopa formed during the measurement period absorb very weakly at 505 nm, 
spectra of the oxidation products of the other catechols overlap in large part with the spectrum 
of the antipyrilquinoneimine (Fig. S9). These data show how complex the influence of 
catechols on the peroxidase catalyzed reactions may be. The value of absorbance will depend 
 20 
on the measurement time, the rates of the reactions between catechols and the 
intermediates/products of the oxidation of standard substrates, the rates of transformation of 
the o-quinones formed (cyclization or decomposition), absorption spectra of the oxidation 
products of catechols, and the ratio of absorption coefficients of the oxidation products of 
standard substrates and catechols at the detection wavelength.  
To illustrate the influence of some of these factors we recorded the UV-Vis spectra 
during oxidation of 4-aminoantipyrine and phenol with HRP in the presence of carbidopa, L-
dopa and dopamine (Fig. 8). In reactions with carbidopa much slower increase of absorbance 
at 505 nm was accompanied by an increase of absorbance at 365 nm, the maximum of 
absorption for 6,7-dihydroxy-3-methylcinnoline, one of the oxidation products of carbidopa 
[24] (Fig. 8B), at a rate much greater than for carbidopa alone (Fig. S9A). In the case of L-
dopa the spectra corresponded to dopachrome (maximum at 475 nm), showing that essentially 
only this chromophore was formed (Fig. 8C), again at a rate much greater than for L-dopa 
alone (Fig. S9B). This conclusion is supported by the final value of absorbance in this 
reaction (0.1734), which corresponds almost exactly to 50 M dopachrome (extinction 
coefficient at 475 nm equal 3600 M-1×cm-1) showing that oxidation (indirect) of L-dopa 
completely depletes hydrogen peroxide from the reaction medium (2 equivalents of H2O2 are 
required for oxidation of L-dopa to dopachrome). The spectra for reactions with dopamine 
indicated formation of a mixture of chromophores (dopaminochrome and 
antipyrilquinoneimine) although formation of a different chromophore (e.g. an oxidized 
adduct of 4-aminoantipyrine to dopamine) cannot be excluded on the basis of UV-Vis spectra 
alone, since the maximum of absorption shifted to ca. 495 nm (Fig. 8D). This difference in 
behavior between L-dopa and dopamine may be explained by the difference in the pKa values 
of their amino groups (8.72 for L-dopa and 10.2 for dopamine [56]), which will result in much 
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slower cyclization of dopaminequinone than dopaquinone (ca. 30 ×) and may allow 





















































































Figure 8. UV-Vis spectra recorded during oxidation of 50 M 4-aminoantipyrine and 1 mM 
phenol with 100 M H2O2 by 0.5 g of HRP in the absence of other compounds (A) and in 
the presence of 80 M carbidopa (B), 80 M L-dopa (C), and 80 M dopamine (D). Spectra 
were recorded immediately after addition of the enzyme (0 min) and then in 1 min intervals 
for 10 min.  
 
Addition of any of the catechols to the formed chromophore (antipyrilquinoneimine) 
caused little changes in absorbance (less than 5% decrease within 15 min), as previously 
demonstrated for dopamine [55]. 
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4. Discussion 
There are numerous reports describing the effects of polyphenols, such as flavonoids 
or gallic acid and its derivatives on the activity of peroxidases [57-62]. These studies usually 
rely on measuring the concentration of oxidized products of standard substrates, such as 
tetramethylbenzidine, o-dianisidine or ABTS for peroxidatic activity. In the case of 
chlorinating activity of myleoperoxidase chlorination of monochlorodimedone or taurine, 
oxidation or chlorination of LDL is usually measured. Rarely, however, these experiments are 
accompanied by monitoring the concentration of hydrogen peroxide and the slower changes 
in the concentration of the oxidized products are therefore interpreted as enzyme inhibition. 
However, when the tested compounds may act as antioxidants, inhibition of the enzyme 
cannot be distinguished by such methods from its antioxidant effects. Inhibition of dityrosine 
formation by myeloperoxidase was reported for ferulic acid, caffeic acid, curcumin and 
quercetin. In this case quenching of the generated tyrosyl radical was simply excluded based 
on the fact that the concentration of tyrosine (0.2 mM) was higher than the concentration of 
the antioxidants (0.1 mM). The rate of tyrosine oxidation, however, was not determined [58]. 
Another report, however, clearly demonstrated scavenging of tyrosyl radicals by quercetin, its 
derivatives and other flavonoids [63]. When the influence of flavonoids, such as rutin, 
taxifolin, epicatechin, quercetin, and kaempferol, on the oxidation LDL by MPO in the 
presence of nitrite was studied, a lag period in the appearance of peroxidized lipids was 
observed. This effect was very similar to the results obtained by us during oxidation of o-
dianisidine by MPO and ABTS by LPO in the presence of carbidopa and other catechols and 
was attributed to the scavenging of the MPO-derived NO2 radical by flavonoids [64]. 
Quercetin and some of its metabolites were shown to inhibit neutrophil-mediated LDL 
oxidation and this effect was also attributed to inhibition of myeloperoxidase [60]. 
Interestingly, modification of quercetin at either 3 or 3’ position did not affect the inhibitory 
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potency, but conjugations at both positions significantly reduced this activity. We have 
recently shown that the presence of a catechol in flavonoid ring B or conjugated phenol 
groups at positions 3 and 4’ enables their redox reaction with o-quinones thus leading to 
apparent inhibition of tyrosinase [65]. Results obtained with myeloperoxidase [60] indicate a 
similar phenomenon in this case.  
The effects of polyphenols on the halogenating activity of myeloperoxidase and the 
pseudohalogenating activity of lactoperoxidase vary. Several studies demonstrated that 
flavonoids enhance these activities [66-69]. This effect was explained by the ability of these 
compounds to reduce compound II of MPO and LPO to the native enzyme thus enabling its 
participation in the (pseudo)halogenating activity. Recently, however, epigallocatechin gallate 
was shown to inhibit hypochlorous acid formation by myeloperoxidase and neutrophils due to 
accumulation of compound II [70].  
Interference with reactions catalyzed by horseradish peroxidase is of particular 
importance because of application of this enzyme in numerous commercial diagnostic tests. 
Several mechanisms have been postulated to explain the effects of various compounds on 
these reactions. For dopamine and dobutamine the mechanism of this interference was 
initially not investigated, although it was speculated that dopamine may be oxidized by HRP 
thus depleting hydrogen peroxide from the reaction medium and preventing formation of 
antipyrilquinoneimine [52, 53]. Later experiments led to a conclusion that dopamine and 4-
aminoantipyrine upon oxidation with peroxidase formed a chromophore with an absorption 
coefficient smaller than antipyrilquinoneimine thus reducing the final absorbance, while for 
dobutamine rapid enzymatic oxidation leading to hydrogen peroxide depletion was postulated 
[55]. However, we consider the postulated mechanism of interference by dopamine 
insufficient. Although a chromophore resulting from coupling of the oxidized 4-
aminoantipyrine with dopamine may form when only these two compounds are present in the 
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mixture, in the presence of excess of another phenolic substrate (in our experiments the ratio 
of phenol to dopamine was 12.5 to 100) such a reaction would be marginal. Our results (Fig. 
8D) indicate that under such conditions formation of dopaminochrome (resulting from 
oxidation of dopamine by 4-aminoantipyril radical) predominates and the 
antipyrilquinoneimine chromophore formed by coupling of oxidized 4-aminoantipyrine with 
either phenol or dopamine is a minor component – it causes the shit of the maximum of 
absorption from 475 nm to 495 nm but does not influence much the final value of absorbance, 
which is close to the value corresponding to dopaminochrome alone. If an adduct between 
dopamine and the oxidation product of 4-aminoantipyrine were formed, it should have an 
absorption coefficient comparable to antipyrilquinoneimines formed with other phenolic 
substrates, many of which are used in commercial diagnostic tests (e.g. phenol, chlorophenol, 
3-hydroxybenzoic acid, 2,4,6-tribromo-3-hydroxybenzoic acid) all giving oxidation products 
with maxima of absorption above 500 nm and much bigger absorption coefficients at this 
wavelength than dopaminochrome. To us the much greater oxidation rate of dobutamine than 
dopamine and different mechanisms of interference for these two compounds [55] are also 
surprising. We have shown that L-dopa and dopamine are oxidized at comparable (very low) 
rates (Fig. S9B and C) and based on the structure of dobutamine one would expect similar 
(smaller rather than bigger - because of the larger size of the side chain) oxidation rate of the 
catechol group in this compound by HRP. We would therefore expect for this compound 
reactions similar to those observed for carbidopa, L-dopa, dopamine and other catechols, 
although enzymatic oxidation of the monophenolic part followed by redox exchange with the 
catechol part cannot be excluded. Appropriate experiments would be required to solve this 
problem.  
Reduction of the oxidation products/intermediates of standard peroxidase substrates 
may also be responsible for interference in peroxidase-based diagnostic tests observed 
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previously for other compounds. A study of interference of several flavonoids with the 
commercial assays used for monitoring free fatty acids and triglycerides demonstrated that the 
concentrations of these analytes were significantly lowered in the presence of quercetin, 
quercetin-3-O-glucuronide, (+)-catechin, kaempferol, and luteolin [71]. This effect was 
attributed to inhibition of peroxidase by these compounds. However, lack of inhibitory effects 
for genistein and naringenin, which do not contain a catechol group or two conjugated 
phenolic groups in the flavonoid rings B and C, indicates that these two compounds, which 
cannot form quinonoid-type products upon oxidation [65], may simply be incapable of 
reducing the oxidation product of 4-aminoantipyrine. Such an effect has been shown for a 
number of flavonoids and phenolic acids in the oxidation of o-dianisidine by horseradish 
peroxidase [33]. All compounds showing strong interference possessed a catechol group, a 
1,2,3-triol group or conjugated phenol groups in flavonoid rings B and C and included, among 
others, catechin, epigallocatechin, keampferol, morin, fisetin, myricetin, and quercetin. For all 
these compounds reduction of meriquinone was demonstrated [33]. Such an effect has also 
been reported for green tea polyphenols [72, 73]. In one of these reports two mechanisms 
responsible for this interference have been postulated: 1) depletion of hydrogen peroxide 
caused by direct oxidation of these compounds by peroxidase and 2) conversion of the 
antipyrilquinoneimine back to substrates (4-aminoantipyrine and 3-hydroxybenzoic acid) [72]. 
This second reaction, however, is not possible. It was postulated because formation of the 
chromophore was restored when additional amount of hydrogen peroxide was added to the 
reaction mixture containing green tea components after prolonged incubation with peroxidase. 
However, such an effect does not require regeneration of the substrate from the final product 
– our results show that the substrate (4-aminoantipyrine) is regenerated from the reaction 
intermediates before coupling with the phenol occurs. 
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Interference in commercial diagnostic tests utilizing peroxidase catalyzed reactions 
was also reported for compounds containing a p-diphenol moiety. Homogentisic acid, present 
at large concentration in the serum and urine of patients with alkaptonuria, interfered with 
tests used for detection of uric acid [74], creatinine [75], and later several more analytes, 
including cholesterol, triglycerides, and glucose [76]. Although hydrogen peroxide depletion 
has been postulated as the main cause of interference by this compound, the exact mechanism 
has not been elucidated. Hemostatic drugs etamsylate and calcium dobesilate (both salts of a 
p-diphenol – 2,5-dihydroxybenzenesulphonic acid) were reported as agents interfering with 
measurements of creatinine, uric acid, triglycerides, and cholesterol [77-79]. We suggest that 
all these p-diphenols may also reduce the oxidation product of 4-aminoantipyrine, just as 
catechols do. Structures of major compounds interfering with the peroxidase-based diagnostic 
tests are shown in Fig. S10.  
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